All Publications

Data provided by UCSF Profiles, powered by CTSI at UCSF
  1. Alasfar S, Chiang TP, Snyder AJ, Ou MT, Boyarsky BJ, Abedon AT, Alejo JL, Cook S, Cochran W, Brigham E, Parker AM, Garonzik-Wang J, Massie AB, Brennan DC, Vannorsdall T, Segev DL, Avery RK. PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection. Transplantation. 2023 01 01; 107(1):181-191. View in PubMed
  2. Alhajri N, Yin K, Locham S, Ou M, Malas MB. Low-volume hospitals are not associated with inferior outcomes after thoracic endovascular aortic repair. J Vasc Surg. 2022 04; 75(4):1202-1210. View in PubMed
  3. Boyarsky BJ, Barbur I, Chiang TP, Ou MT, Greenberg RS, Teles AT, Krach MR, López JI, Garonzik-Wang JM, Avery RK, Massie AB, Segev DL, Werbel WA. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271. View in PubMed
  4. Boyarsky BJ, Chiang TP, Teles AT, Greenberg RS, Krach MR, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL, Werbel AWA. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138. View in PubMed
  5. Ou MT, Boyarsky BJ, Motter JD, Greenberg RS, Teles AT, Ruddy JA, Krach MR, Jain VS, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174. View in PubMed
  6. Strauss AT, Hallett AM, Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Tobian AAR, Massie AB, Hamilton JPA, Garonzik-Wang JM, Segev DL. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856. View in PubMed
  7. Ou MT, Boyarsky BJ, Chiang TPY, Bae S, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123. View in PubMed
  8. Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, López JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588. View in PubMed
  9. Boyarsky BJ, Chiang TP, Ou MT, Werbel WA, Massie AB, Segev DL, Garonzik-Wang JM. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83. View in PubMed
  10. Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332. View in PubMed
  11. Ou MT, Boyarsky BJ, Zeiser LB, Po-Yu Chiang T, Ruddy J, Van Pilsum Rasmussen SE, Martin J, St Clair Russell J, Durand CM, Avery RK, Werbel WA, Cooper M, Massie AB, Segev DL, Garonzik-Wang JM. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713. View in PubMed
  12. Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Clarke WA, Tobian AAR, Massie AB, Segev DL, Garonzik Wang JM. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53. View in PubMed
  13. Boyarsky BJ, Ou MT, Greenberg RS, Teles AT, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57. View in PubMed
  14. Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 08; 80(8):1098-1099. View in PubMed
  15. Dakour-Aridi H, Ou MT, Locham S, Mathlouthi A, Farber A, Malas MB. Anemia as an independent predictor of adverse outcomes after carotid revascularization. J Vasc Surg. 2020 11; 72(5):1711-1719.e2. View in PubMed
  16. Tracey BM, Mayo LN, Le CT, Chen VY, Weichsel J, Renner CY, Li J, Tsai JJ, Kalarn SP, Ou MT, Chang LY, Mohammed TK, Mohammed ISK, Shah KA, Thompson GM, Jones AMK, Im LT, Kaleem MA, Saeedi OJ. Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry. Sci Rep. 2019 12 27; 9(1):20178. View in PubMed
  17. Dakour-Aridi H, Ou M, Locham S, AbuRahma A, Schneider JR, Malas M. Outcomes following Eversion versus Conventional Endarterectomy in the Vascular Quality Initiative Database. Ann Vasc Surg. 2020 May; 65:1-9. View in PubMed
  18. Ou MT, Kleiman H, Kalarn S, Moradi A, Shukla S, Danielson M, Kaleem M, Boland M, Robin AL, Saeedi OJ. A Pilot Study on the Effects of Physician Gaze on Patient Satisfaction in the Setting of Electronic Health Records. J Acad Ophthalmol (2017). 2019 Jul; 11(2):e24-e29. View in PubMed
  19. Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH, Kang HC, Zhang J, Xu J, Chen R, Park H, Andrabi SA, Kang SU, Gonçalves RA, Liang Y, Zhang S, Qi C, Lam S, Keiler JA, Tyson J, Kim D, Panicker N, Yun SP, Workman CJ, Vignali DA, Dawson VL, Ko HS, Dawson TM. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016 09 30; 353(6307). View in PubMed